Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme
- Status
- COMPLETED
- Phase
- PHASE4
Exparel vs Block for ACL Reconstruction
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone-Dexmedetomidine Combination on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy
- Status
- COMPLETED
- Phase
- PHASE3
Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
- Status
- RECRUITING
- Phase
- PHASE2
Pre vs Post Block in Total Knee Arthroplasty (TKA)
- Status
- COMPLETED
- Phase
- PHASE4
Lactoferrin Use in ICU Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH
- Status
- RECRUITING
- Phase
- NA
Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia
- Status
- UNKNOWN
- Phase
- PHASE2
Isatuximab, Bela Maf, Pom, and Dex in Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Comparison Between Bupivacaine and Bupivacaine- Dexamethasone QLB for Postoperative Analgesia
- Status
- COMPLETED
- Phase
- PHASE1
Isa-Pom-Dex in Elderly/Frail Subjects With RRMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease
- Status
- RECRUITING
- Phase
- PHASE2
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
The Danish Out-of-Hospital Cardiac Arrest Study
- Status
- RECRUITING
- Phase
- PHASE3
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
- Status
- COMPLETED
- Phase
- PHASE3
Immune Thrombocytopenia Management in Adults
- Status
- UNKNOWN
- Phase
- PHASE4